新冠疫情高峰期间英国和爱尔兰重大重建手术安全性:多中心国家队列研究
该多中心国家队列研究纳入英国和爱尔兰COVID-19高峰12周内418例重大重建手术患者,平均手术时间7.5小时、住院12天,癌症(59.8%)和创伤(29.4%)为主要指征。术后30天死亡率为0.2%(1例COVID阴性患者死亡),总并发症率20.8%,COVID状态与并发症无相关性;8名医护人员术后感染COVID-19,其中7例发生于前三周。结论认为在充分防护下,重大重建手术对患者和医护人员是安全的。
要点
- COVID-19高峰期间重大重建手术30天死亡率0.2%,总并发症率20.8%。
- 癌症(59.8%)和创伤(29.4%)为最常见手术指征。
- COVID状态与主要或次要并发症无相关性。
核心结论
- 在充分防护措施下,COVID-19危机期间行重大重建手术对患者和医护人员是安全的,患者安全与手术结局与COVID前时代相同。
研究设计与样本
- 英国和爱尔兰多中心国家队列研究,纳入COVID-19高峰12周内所有重大重建手术,共418例患者。
主要发现
- 418例患者平均手术时间7.5小时、住院12天;癌症占59.8%、创伤占29.4%;4.5%患者存在COVID-19感染。
- 术后30天死亡率为0.2%(1例COVID阴性患者死亡),总并发症率为20.8%。
- COVID状态与主要或次要并发症无相关性;8名医护人员术后感染COVID-19,其中7例发生于前三周。
临床怎么用
- 该队列可作为所有外科专业重大手术的替代参考,用于向患者告知围手术期COVID-19风险。
- 在充分防护条件下,不应因COVID-19高峰而普遍取消或延迟重大重建手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The safety of surgery during and after the coronavirus disease-2019 (COVID-19) pandemic is paramount. Early reports of excessive perioperative mortality in COVID-positive patients promoted the widespread avoidance of operations. However, cancelling or delaying operations for cancer, trauma, or functional restitution has resulted in increased morbidity and mortality. METHODS: A national multicentre cohort study of all major reconstructive operations carried out over a 12-week period of the 'COVID-19 surge' in the United Kingdom and Ireland was performed. Primary outcome was 30-day mortality and secondary outcome measures were major complications (Clavien-Dindo grade ≥3) and COVID-19 status of patients and healthcare professionals before and after surgery. RESULTS: A total of 418 patients underwent major reconstructive surgery with a mean operating time of 7.5 hours and 12 days' inpatient stay. Cancer (59.8%) and trauma (29.4%) were the most common indications. COVID-19 infection was present in 4.5% of patients. The 30-day post-operative mortality was 0.2%, reflecting the death of one patient who was COVID-negative. Overall complication rate was 20.8%. COVID status did not correlate with major or minor complications. Eight healthcare professionals developed post-operative COVID-19 infection, seven of which occurred within the first three weeks. CONCLUSIONS: Major reconstructive operations performed during the COVID-19 crisis have been mostly urgent cases involving all surgical specialties. This cohort is a surrogate for all major operations across all surgical specialties. Patient safety and surgical outcomes have been the same as in the pre-COVID era. With adequate precautions, major reconstructive surgery is safe for patients and staff. This study helps counsel patients of COVID-19 risks in the perioperative period.
引用
- Patel NG, Reissis D, Mair M, et al. Safety of major reconstructive surgery during the peak of the COVID-19 pandemic in the United Kingdom and Ireland - multicentre national cohort study. J Plast Reconstr Aesthet Surg. 2020. PMID: 33402316. doi:10.1016/j.bjps.2020.12.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。